Down-regulation of NADPH-diaphorase (nitric oxide synthase) may account for the pharmacological activities of Cu(II)2(3,5-diisopropylsalicylate)4
- 1 November 1995
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 60 (2) , 133-148
- https://doi.org/10.1016/0162-0134(95)00008-c
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl esterLife Sciences, 1993
- Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cordLife Sciences, 1993
- Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats.Stroke, 1993
- Nitric oxide inhibition intensifies cold-restraint induced gastric ulcers in ratsCellular and Molecular Life Sciences, 1993
- Nitric oxide synthase in rat brain is predominantly located at neuronal endoplasmic reticulum: an electron microscopic demonstration of NADPH-diaphorase activityNeuroscience Letters, 1992
- Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide.Stroke, 1992
- Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in miceBiochemical and Biophysical Research Communications, 1991
- Enzymatic formation of nitrogen oxides from L-arginine in bovine brain cytosolBiochemical and Biophysical Research Communications, 1989
- Copper complexes of non-steroidal antiinflammatory agents: Analgesic activity and possible opioid receptor activationInflammation Research, 1987
- Activation of cerebral guanylate cyclase by nitric oxideBiochemical and Biophysical Research Communications, 1977